Nipah virus: pathogenesis, genome, diagnosis, and treatment
Applied Microbiology and Biotechnology · 01.07.2025 · 109 (1)
DOI: 10.1007/s00253-025-13474-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 01.07.2025. Verfasst von Rishav Madhukalya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), 247667, Roorkee, India. Hauptthemen laut MEDLINE: Nipah Virus, Henipavirus Infections, Genome, Viral. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LifeArc.
Abstract (Originalsprache)
The highly infectious Nipah virus (NiV) is classified under the Paramyxoviridae family and is categorized under the genus Henipavirus. NiV spreads to humans through zoonotic transmission from reservoir host bats and other intermediate hosts. It is highly contagious and has a high case fatality rate (CFR) of ~ 40-80%. Only sporadic outbreaks have been reported so far, but like SARS-CoV2, NiV has a high pandemic potential and has been put on the World Health Organization (WHO) priority pathogen list. Currently, no clinically approved antivirals, immunotherapy, or vaccines are available to tackle NiV infection, thereby necessitating further research into its life cycle, transmission, and pathogenesis. This detailed review outlines the origin and spread of the Nipah virus, its modes of transmission, risk factors, its genome, key proteins, pathogenesis, and clinical features. We also discuss different diagnostic approaches and ongoing research to develop therapies ranging from antibodies to vaccines. KEY POINTS: •Pandemic preparedness for emerging and re-emerging viruses. •Novel approaches for diagnostics and therapeutics for Nipah viruse. •Global threat from biosafety level 4 pathogens. •Animal models for Nipah virus research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), 247667, Roorkee, India.
- Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana- 121001, India.
- Institutes of Advanced Virology, Bio 360 Life Science Park, Trivandrum, Kerala- 695317, India.
- Trivedi School of Biosciences, Ashoka University, Sonipat, Haryana, India.
- Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana- 121001, India. supratik@thsti.res.in.
- Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), 247667, Roorkee, India. rajesh.kumar@bt.iitr.ac.in.
Förderung
- LifeArc
Zitieren
APA
Madhukalya, R., Yadav, U., Parray, H. A., Raj, N., Lupitha, S. S., Kumar, V., Saroj, A., Agarwal, V., Kumar, D., Das, S., & Kumar, R. (2025). Nipah virus: pathogenesis, genome, diagnosis, and treatment. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13474-6
Vancouver
Madhukalya R, Yadav U, Parray HA, Raj N, Lupitha SS, Kumar V, et al. Nipah virus: pathogenesis, genome, diagnosis, and treatment. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13474-6
BibTeX
@article{Madhukalya2025,
author = {Madhukalya, Rishav and Yadav, Urvashi and Parray, Hilal Ahmad and Raj, Nisha and Lupitha, Santhik Subhasingh and Kumar, Vivek and Saroj, Anjali and Agarwal, Vidushi and Kumar, Dilip and Das, Supratik and Kumar, Rajesh},
title = {Nipah virus: pathogenesis, genome, diagnosis, and treatment},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
volume = {109},
number = {1},
doi = {10.1007/s00253-025-13474-6}
}
EUVIMED